These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8899801)

  • 41. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study.
    von Schrenck T; Moran TH; Heinz-Erian P; Gardner JD; Jensen RT
    Am J Physiol; 1988 Oct; 255(4 Pt 1):G512-21. PubMed ID: 3177648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenocarcinoma of the pancreas in azaserine-treated rats.
    Longnecker DS; Curphey TJ
    Cancer Res; 1975 Aug; 35(8):2249-58. PubMed ID: 1097106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Size and number of nuclei differ in normal and neoplastic acinar cells from rat pancreas.
    Morgan RG; Schaeffer BK; Longnecker DS
    Pancreas; 1986; 1(1):37-43. PubMed ID: 3494991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of growth and cell turnover of preneoplastic lesions and of prostaglandin levels in rat pancreas by dietary fish oil.
    Appel MJ; Woutersen RA
    Carcinogenesis; 1994 Oct; 15(10):2107-12. PubMed ID: 7955040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidermal growth factor receptor expression in pancreatic lesions induced in the rat by azaserine.
    Visser CJ; de Weger RA; van Blokland WT; Seifert-Bock I; Kobrin MS; Korc M; Woutersen RA
    Br J Cancer; 1996 Jul; 74(1):92-8. PubMed ID: 8679465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of dietary fatty acids on the early stages of neoplastic induction in the rat pancreas. Changes in fatty acid composition and development of atypical acinar cell nodules.
    Khoo DE; Flaks B; Oztas H; Williamson RC; Habib NA
    Int J Exp Pathol; 1991 Oct; 72(5):571-80. PubMed ID: 1742210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas.
    Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
    Gastroenterology; 1989 Feb; 96(2 Pt 1):462-9. PubMed ID: 2910761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of receptors for gut peptides in pancreata of BOP-treated and control hamsters.
    Tang C; Biemond I; Appel MJ; Visser CJ; Woutersen RA; Lamers CB
    Carcinogenesis; 1996 Oct; 17(10):2171-5. PubMed ID: 8895485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters.
    Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Carcinogenesis; 1990 Dec; 11(12):2223-6. PubMed ID: 2265473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of dietary galactooligosaccharide on azaserine-induced acinar pancreatic carcinogenesis in male Wistar rats.
    Appel MJ; Wijnands MV; Woutersen RA
    Nutr Cancer; 1997; 29(1):35-41. PubMed ID: 9383782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Derivation of ductlike cell lines from a transplantable acinar cell carcinoma of the rat pancreas.
    Pettengill OS; Faris RA; Bell RH; Kuhlmann ET; Longnecker DS
    Am J Pathol; 1993 Jul; 143(1):292-303. PubMed ID: 8391218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel expression of gastrin (CCK-B) receptors in pancreatic carcinomas and dysplastic pancreas from transgenic mice.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Am J Surg; 1994 Jan; 167(1):120-6; discussion 126-7. PubMed ID: 8311122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A reduced pancreatic protein secretion in response to cholecystokinin (CCK) in the obese Zucker rat correlates with a reduced receptor capacity for CCK.
    Praissman M; Izzo RS
    Endocrinology; 1986 Aug; 119(2):546-53. PubMed ID: 3015550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lesions induced in rodent pancreas by azaserine and other pancreatic carcinogens.
    Longnecker DS
    Environ Health Perspect; 1984 Jun; 56():245-51. PubMed ID: 6332732
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancing effect of partial gastrectomy on pancreatic carcinogenesis.
    Watanapa P; Flaks B; Oztas H; Deprez PH; Calam J; Williamson RC
    Br J Cancer; 1992 Mar; 65(3):383-7. PubMed ID: 1558791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unexpected high incidence of cholecystokinin-B/gastrin receptors in human medullary thyroid carcinomas.
    Reubi JC; Waser B
    Int J Cancer; 1996 Sep; 67(5):644-7. PubMed ID: 8782652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific binding of cholecystokinin, estradiol and somatostatin to human pancreatic cancer xenografts.
    Singh P; Townsend CM; Poston GJ; Reubi JC
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):759-67. PubMed ID: 1683561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue.
    Reubi JC; Waser B; Gugger M; Friess H; Kleeff J; Kayed H; Büchler MW; Laissue JA
    Gastroenterology; 2003 Jul; 125(1):98-106. PubMed ID: 12851875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition by retinoids of the growth of azaserine-induced foci in the rat pancreas.
    Roebuck BD; Baumgartner KJ; Thron CD; Longnecker DS
    J Natl Cancer Inst; 1984 Jul; 73(1):233-6. PubMed ID: 6610790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and localization of cholecystokinin-binding sites on rat pancreatic plasma membranes and acinar cells: a biochemical and autoradiographic study.
    Rosenzweig SA; Miller LJ; Jamieson JD
    J Cell Biol; 1983 May; 96(5):1288-97. PubMed ID: 6841449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.